NEW YORK, NEW YORK - OCTOBER 03: In this photo illustration, a medical syringe and vials of the Pfizer US pharmaceutical corporation and BioNTech German biotechnology 2021 company logos are seen on October 03, 2021 in New York City. Pfizer and BioNTech announced its conclude phase 3 study of COVID-19 vaccine candidate with 95% primary efficacy analysis, as the media reported on 18 November 2020. (Photo Illustration by Cindy Ord/Getty Images for Pfizer/BioNTech)

(AP) – U.S. health advisers are urging a booster dose of Pfizer’s COVID-19 vaccine for kids ages 5 to 11. The Centers for Disease Control and Prevention will consider the advice. If the CDC agrees as expected, it would open a third COVID-19 shot to healthy elementary-age kids, just like what is already recommended for everybody 12 and older. Regulators this week authorized the extra dose to be given at least five months after youngsters’ last shot. CDC’s advisers endorsed it during a public meeting Thursday.